River Wealth Advisors LLC Eli Lilly & CO Transaction History

River Wealth Advisors LLC

$692 Million
Q2 2024

A detailed history of River Wealth Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, River Wealth Advisors LLC holds 7,580 shares of LLY stock, worth $6.21 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

7,580

Previous 5,577 35.92%

Holding current value

$6.21 Million

Previous $4.34 Million 58.18%

% of portfolio

0.99%

Previous 0.64%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $1.45 Million - $1.82 Million	2,003 Added 35.92%	7,580 $6.86 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $2.29 Million - $3.06 Million	3,859 Added 224.62%	5,577 $4.34 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $438,533 - $516,973	835 Added 94.56%	1,718 $1 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $2,608 - $3,595	6 Added 0.68%	883 $474,000
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $350 - $468	1 Added 0.11%	877 $411,000
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $40,071 - $47,061	129 Added 17.27%	876 $300,000
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $240,197 - $279,878	747 New	747 $273,000
Q1 2019 May 07, 2019	SELL	$111.31 - $131.02 $66,674 - $78,480	-599 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$105.9 - $118.64 $60,786 - $68,099	-574 Reduced 48.93%	599 $69,000
Q3 2018 Nov 09, 2018	SELL	$85.86 - $107.31 $31,081 - $38,846	-362 Reduced 23.58%	1,173 $126,000
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $116,199 - $133,360	1,535 New	1,535 $131,000
Q1 2018 May 02, 2018	SELL	$74.21 - $87.6 $192,871 - $227,672	-2,599 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $43,428 - $46,581	-530 Reduced 16.94%	2,599 $220,000
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $241,152 - $267,654	3,129	3,129 $268,000

Others Institutions Holding LLY

# of Institutions

3,912

Shares Held

765M

Call Options Held

6.35M

Put Options Held

7.96M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $778B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of River Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Wealth Advisors LLC with notifications on news.

Account

River Wealth Advisors LLC Eli Lilly & CO Transaction History